Introduction
Percutaneous coronary interventions (PCIs), are the most common invasive procedures used to treat acute coronary syndrome (ACS), followed by coronary artery bypass graftings (CABGs). Randomized clinical trials comparing PCIs and non-invasive treatment of ACS mostly favor the invasive approach. However, the real-life impact of these invasive treatments on the hospitalization cost, length of stay in hospital and inhospital mortality in Belgium is not well known. This study aims at providing some insights on these questions using retrospective data from the IMS RWD Hospital Data -Belgium (2013).
Conclusions
Although information on the baseline characteristics of the selected patients is limited, the findings of this retrospective study seem to support randomized clinical trials in showing better outcomes associated with PCI. PCI significantly decreases the LOS and the in-hospital mortality in patients with a myocardial infarction, at a limited additional cost.
The objective of the study was to use retrospective hospital data from the IMS RWD Hospital Data -Belgium (full year 2013) in order to assess whether, in a real life setting, PCI has an impact on such outcomes as hospitalization costs, length of stay (LOS) and mortality in patients hospitalized for acute coronary syndromes in Belgium. • Cost of hospitalization: Cost of drugs is documented as such in the database. Hotel and procedure cost can be estimated by a merge with average costs per APR-DRG/ level of severity as published by Belgian Authorities.
Time frame of study: full calendar year 2013
Selection of eligible population:
• Hospitalizations were selected based on the presence of an ICD-9-CM (primary) diagnosis code corresponding to acute coronary syndrome (ACS, including ST-elevated
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• 2,528 STEMI, 2,815 NSTEMI and 407 UA hospitalizations were retrieved from the database, with respectively 1,457 (57.6%), 1,194 (42.4%) and 30 (7.4%) of them treated invasively.
• CABG was performed in only 3.5% of STEMIs (n=88), 7.9% of non-STEMIs (n=222) and 0.2% of UAs (n=1).
• CABGs were associated with higher costs and longer stay in hospital in both STEMI and NSTEMI (see Figure 1 ; all p>0.001).
• When comparing PCI-treated vs. not invasively treated):
• PCI resulted in higher costs in STEMI (€9,028 vs. €6,267; p<0.001), NSTEMI (€7,905 vs. 6,275; p<0.001) and UA (€9,084 vs. €4,714; p<0.001).
• However, LOS of patients undergoing PCI was significantly lower in STEMI (6.2 vs. 8.6 days; p<0.001) and NSTEMI (5.6 vs. 9.2; p<0.001).
• In-hospital mortality in patients with PCI was lower in both STEMI (6.2% vs. 22.4%; p<0.001) and NSTEMI (1.6% vs. 8.2%; p<0.001).
• LOS (5.5 vs. 5.9 days) and mortality (0.0% vs. 3.2%) were not significantly different in UA.
myocardial infarction [STEMI] , non-STEMI, unstable angina [UA]) (see Table 2 )
Identification of invasive surgeries:
• Invasive coronary interventions were identified based on ICD-9-CM procedure codes corresponding to PCI and CABG (see Table 2 )
Study endpoints: average length of stay inhospital (LOS), average cost of hospitalization and mortality in-hospital Statistical analysis: Comparisons were performed using a Wilcoxon non-parametrical test for cost/ LOS and a Chi-square for mortality. 
